Pathobiology and clinical impact of reperfusion injury

Journal of Thrombosis and Thrombolysis: An International Journal for Clinicians and Scientists

Volumn 2, Issue 3, 1995, Pages 177-186

  Birnbaum, Yochai ^a   Leor, Jonathan ^a   Kloner, Robert A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

complement; neutrophils; oxygen free radicals; reperfusion injury

Indexed keywords

EID: 0000673261     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/BF01062708     Document Type: Article

References (132)

1. Postreperfasion inflammation: A model for reaction to injury in cardiovascular disease
2. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
3. Mechanism of myocardial “stunning
4. The stunned myocardium: Prolonged postischemic ventricular dysfunction
5. Intracoronary infusion of streptokinase in patients with acute myocardial infarction: Effects of reperfusion on left ventricular performance
6. A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction
7. Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction
8. Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction
9. Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction
10. Prolonged wall motion abnormalities after chest pain at rest in patients with unstable angina: A possible manifestation of myocardial stunning
11. Variant angina pectoris with prolonged electrical and mechanical stunning
12. Coronary vasospasm as a cause of stunned myocardium
13. Stunned myocardium following coronary spasm
14. Does the myocardium become “stunned” after episodes of angina at rest, angina on effort, and coronary angioplasty?
15. Transient changes in left ventricular mechanics during attacks of Prinzmetal's angina: A two-dimensional echocardiographic study
16. Sequence of events in angina at rest: primary reduction in coronary flow
17. Exercise echocardiography: A clinical practical addition in the evaluation of coronary artery disease
18. Exercise-induced left ventricular dysfunction in coronary heart disease: A model for studying the stunned myocardium in man
19. Persistence of contractile impairment in the absence of flow abnormalities after exercise: Evidence for myocardial stunning in patients with stable angina
20. Stunned left ventricular myocardium after exercise treadmill testing in coronary artery disease
21. Left ventricular dysfunction following transient ischaemia induced by transluminal coronary angioplasty. Beneficial effects of calcium antagonists against post-ischaemic myocardial stunning
22. Scintigraphic and hemodynamic demonstration of transient left ventricular dysfunction immediately after uncomplicated coronary artery bypass grafting
23. Sequential postoperative assessment of left ventricular performance with gated cardiac blood pool imaging following aortocoronary bypass surgery
24. Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery
25. Physiology of the transplanted heart
26. Current problems in cardiac transplantation
27. Does reperfusion injury exist in humans?
28. Reperfusion arrhythmias: Experimental and clinical aspects
29. Ventricular tachyarrhythmias in Prinzmetal's variant angina: Clinical significance and relation to the degree and time course ST segment elevation
30. Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal's angina
31. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death
32. Lifethreatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary artery spasm
33. The reasons why clinical cardiologists disregard reperfusion arrhythmias
34. Polymorphous ventricular tachycardia early after acute myocardial infarction
35. Role of selectins, a new family of adhesion molecules, in ischemia-reperfusion injury
36. The “no-reflow” phenomenon following temporary coronary occlusion in the dog
37. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog
38. Role of neutrophils in myocardial ischemia and reperfusion
39. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow
40. Influx of neutrophils into the walls of large epicardial coronary arteries in response to ischemia/reperfusion
41. Scintigraphic evidence of the “no-refiow” phenomenon in human begins after coronary thrombolysis
42. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction
43. Progressive decrease in coronary vein flow during reperfusion in acute myocardial infarction: Clinical documentation of the no reflow phenomenon after successful thrombolysis
44. Myocardial neutrophil accumulation during reperfusion after reversible or irreversible ischemic injury
45. The effect of streptokinase on intramyocardial hemorrhage infarct size, and the no-reflow phenomenon during coronary reperfusion
46. Effect of coronary reperfusion on myocardial hemorrhage and infarct healing
47. Cardiac morphologic findings in patients with acute myocardial infarction treated with recombinant tissue plasminogen activator
48. Free radicals and myocardial ischemia: overview and outlook
49. Recombinant Superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium
50. Myocardial reperfusion injury: Role of oxygen radicals and potential therapy with antioxidants
51. Oxygen-derived free radicals in postischemic tissue injury
52. Reperfusion injury and oxygen free radicals: A review
53. Reactive oxygen metabolites, neutrophils, and the pathogenesis of ischemic-tissue/reperfusion
54. Deleterious effects of oxygen radicals in ischemia/reperfusion: Resolved and unresolved issues
55. The mitochondrial generation of hydrogen peroxide: General properties and effect of hyperbaric oxygen
56. Mitochondrial production of superoxide anion and its relationship to the antimicyn-insensitive respiration
57. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria
58. Oxygen free radicals and myocardial damage: Protective role of thiol-containing agents
59. Significance of xanthine oxidase on capillary endothelial cells
60. Absence of detectable xanthine oxidase in human myocardium
61. Free radical producing enzymes, xanthine oxidase, is undetectable in human hearts
62. Superoxide dismutase: An enzymatic function for erythrocuperein (hemocuperein)
63. Myocardial injury mediated by oxygen free radicals
64. Polymorphonuclear leukocytemediated cell and tissue injury: Oxygen metabolites and their relations to human disease
65. Protection against adrenochrome-induced myocardial damage by various pharmacological interventions
66. Changes in the antioxidant defensive system during open heart operations in humans
67. Oxygen-mediated myocardial damage during ischemia and reperfusion: Role of the cellular defenses against oxygen toxicity
68. Prolonged coronary occlusion results in reduced free radical production upon reperfusion in dogs
69. Myocardial reperfusion injury: Mechanism and management—A review
70. Lipid peroxidation associated with successful thrombolysis
71. Effect of Superoxide generation on rat heart mitochondrial pyruvate utilization
72. On the involvement of a mitochondrial pore in reperfusion injury
73. Role of oxygen radicals in myocardial stunning
74. Role of altered calcium homeostasis in stunned myocardium
75. Proarrhythmic effects of an oxygen-derived free radical generating system on action potentials recorded from guinea pig ventricular myocardium: A possible cause of reperfusion-induced arrhythmias
76. Abnormal electrical activity induced by free radical generating systems in isolated cardiocytes
77. Reperfusion induced arrhythmias are caused by generation of free radicals
78. Clastogenic factor in ischemia-reperfusion injury during open heart surgery: Protective effect of allopurinol
79. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock
80. Complement activation and inhibition in myocardial ischemia and reperfusion injury
81. The complement system in myocardial ischaemia/reperfusion injury
82. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils
83. Oxidative stress in patients with unstable angina
84. Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: Potential mechanisms for free radical generation
85. Transient release of lipid peroxides after coronary artery balloon angioplasty
86. Occurrence of oxidative stress during reperfusion of the human heart
87. Are indirect markers an accurate measure of free radical activity following primary angioplasty reperfusion in acute myocardial infarction (abstract)
88. Oxygen-derived free radicals and myocardial reperfusion injury: An overview
89. Demonstration of myocardial reperfusion injury in humans: Results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction
90. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial “stunning” is a manifestation of reperfusion injury
91. 2 delivery
92. Intravenous Fluosol in the treatment of acute myocardial infarction
93. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction
94. Effect of allopurinol (zyloric) on patients undergoing open heart surgery
95. A randomized controlled trial of allopurinol in coronary bypass surgery
96. Influence of allopurinol on cardiac complications in open heart operations
97. Allopurinol pretreatment improves postoperative recovery and reduced lipid peroxidation in patients undergoing coronary artery bypass grafting
98. Effects of allopurinol on oxygen stress status during open heart surgery
99. Bochenek A, Religa Z, Spyt TJ, et al. Protective influence of pretreatment with allopurinol on myocardial function in patients undergoing coronary artery surgery. Eur J Cardiothorac Surg 1990:538–542.
100. Allopurinol therapy of ischemic heart disease with infarct extension
101. Clinical experience of coenzyme Q10 to enhance intraoperative myocardial protection in coronary artery revascularization
102. Effectiveness of coenzyme Q10 on myocardial preservation during hypothermic cardioplegic arrest
103. Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting
104. Activation of complement by hydroxyl radical in thermal injury
105. Mechanism of complement activation after coronary artery occlusion: Evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human Clq in vivo
106. Induction of cell-associated interleukin 1 through stimulation of the adhesion-promoting proteins LFA-1 (CD11a/CD18) and CR3 (CD11b/CD18) of human monocytes
107. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
108. Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting
109. Leukocyte depleted reperfusion of transplanted human hearts: A randomized, double-blind clinical trial
110. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury
111. Intravenous adenosine and lidocaine to limit reperfusion injury during acute myocardial infarction: Preliminary data
112. Reperfusion is required for the induction of cytokine and intracellular adhesion molecule-1 (ICAM-1) synthesis in ischemic hearts (abstract)
113. Interleukin-8 is not involved in the increased chemotactic activity of peripheral blood plasma during acute myocardial infarction
114. Cell adhesion molecules in coronary artery disease
115. Resident cardiac mast cells degranulate and release performed TNF-alpha during ischemia/reperfusion injury (abstract)
116. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium
117. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury
118. Combined inhibition of P-selectin and ICAM-1 reduces neutrophil accumulation and preserves coronary blood flow in the postischemic myocardium (abstract)
119. x-containing oligosaccharide attenuates myocardial reperfusion injury in cats
120. Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium
121. Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heart
122. Cdwl8 dependent adhesion of leukocytes to endothelium and its relevance for cardiac reperfusion
123. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury
124. A chimeric IgG4 monoclonal antibody directed against CD 18 reduces infarct size in a primate model of myocardial ischemia and reperfusion
125. Effect of antiCD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs
126. Antibody to PECAM-1 reduces myocardial infarct size (abstract)
127. Angiotensin II receptor blockade decreases neutrophil-mediated myocardial reperfusion injury (abstract)
128. Ventricular septal rupture during ibuprofen therapy for pericarditis after acute myocardial infarction
129. Deleterious effects of methylprednisolone in patients with myocardial infarction
130. Indomethacin-induced scar thinning after experimental myocardial infarction
131. Superoxide dismutase does not cause scar thinning after myocardial infarction